Skip to content
The Policy VaultThe Policy Vault

Lenvima (lenvatinib) — Medica

Anaplastic thyroid carcinoma

Initial criteria

  • age ≥ 18 years
  • Medication is used in combination with Keytruda (pembrolizumab intravenous injection)

Approval duration

1 year